Vir Biotechnology Inc.

11/18/2024 | Press release | Distributed by Public on 11/18/2024 20:25

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program